Digital support for pulmonary fibrosis
Alex Therapeutics, based in Stockholm, Sweden, specializes in developing digital therapeutics (DTx) for various medical conditions. Their core offering, the "Alex DTx Platform," integrates evidence-based psychological methodologies, including Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), with artificial intelligence (AI) to create personalized digital treatments. This platform is designed to address unmet needs among patients by providing standalone, patient-centric treatments that can be accessed via smartphones or tablets.